0000000000414403

AUTHOR

I. Febrer

showing 3 related works from this author

Sensitization in early age to food allergens in children with atopic dermatitis

2007

Background: Clinical and laboratory evidence increasingly supports the notion that food allergy plays a role in the pathogenesis of atopic dermatitis (AD). However, the prevalence of clinically significant food hypersensitivity among children with AD remains an unanswered question. Objective: To prospectively determine the prevalence of IgE-mediated food hypersensitivity among patients referred to a dermatology department for evaluation of AD, and to analyze the clinical relevance of these sensitizations in AD. Methods: We studied 44 infants of both sexes, aged less than 12 months old, who attended the dermatology department with symptoms of AD. Compliance with Hanifin-Rajka criteria was co…

MalePulmonary and Respiratory Medicinefood hypersensitivitymedicine.medical_specialtyEggsImmunologyEgg Proteins DietarySeverity of Illness IndexDermatitis Atopicfood challengeAntibody SpecificityFood allergyElimination dietPrevalencemedicineAnimalsHumansImmunology and AllergyClinical significanceProspective StudiesAge of OnsetFood allergensSensitizationSkin Testsfood allergyatopic dermatitisbusiness.industryInfantegg allergyGeneral MedicineAtopic dermatitisAllergensImmunoglobulin EMilk Proteinsmedicine.diseaseFood hypersensitivityDermatologycow's milk allergymedicine.anatomical_structureEgg allergyCattleFemaleInfant FoodMilk HypersensitivitybusinessChickensFood Hypersensitivity
researchProduct

Tinea corporis en un paciente de piel negra: importancia del examen directo

2011

business.industryPediatrics Perinatology and Child HealthMedicinebusinessPediatricsRJ1-570Anales de Pediatría
researchProduct

Fluticasone in mild to moderate atopic dermatitis relapse: A randomized controlled trial

2018

Background: The long-term efficacy of corticosteroids to prevent atopic dermatitis (AD) relapses has partially been addressed in children. This study compared an intermittent dosing regimen of fluticasone propionate (FP) cream 0.05% with its vehicle base in reducing the risk of relapse in children with stabilized AD. Methods A randomized controlled, multicentric, double-blind trial was conducted. Children (2-10 years) with mild/moderate AD (exclusion criteria: > 30% affected body surface area and/or head) were enrolled into an Open-label Stabilization Phase (OSP) of up to 2 weeks on twice daily FP. Those who achieved treatment success entered the Double-blind Maintenance Phase (DMP). They w…

MalePulmonary and Respiratory Medicinemedicine.medical_specialtyImmunologyAnti-Inflammatory AgentsLower riskFluticasone propionateIntermittent dosingFluticasone propionateDermatitis Atopiclaw.invention030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineDouble-Blind MethodRandomized controlled triallaw030225 pediatricsInternal medicineSecondary PreventionmedicineAtopic dermatitis Clinical trial Fluticasone propionate Intermittent dosing PreventionHumansImmunology and AllergyChildFluticasoneAtopic dermatitisBody surface areabusiness.industryPreventionGeneral MedicineAtopic dermatitismedicine.diseaseClinical trialRegimenChild PreschoolRelative riskFluticasoneFemalebusinessmedicine.drug
researchProduct